Literature DB >> 1697200

The role of adenosine in the hyperaemic response of the hepatic artery to portal vein occlusion (the 'buffer response').

R T Mathie1, B Alexander.   

Abstract

1. Adenosine has been shown to be responsible for the hyperaemic response of the hepatic artery to portal vein occlusion (the hepatic arterial 'buffer response'). 2. The effect of adenosine receptor blockade and of adenosine uptake inhibition on the hepatic arterial response to portal vein occlusion was investigated in three groups of anaesthetized dogs. 3. Venous return and arterial blood pressure were maintained during periods of portal occlusion by establishing a side-to-side portacaval shunt. Hepatic artery and portal vein blood flows were measured with electromagnetic flowmeters. 4. Hepatic arterial infusions of 8-phenyltheophylline (500 micrograms kg-1 and 3-isobutyl-1-methylxanthine min-1) and 3-isobutyl-1-methylxanthine (75 micrograms kg-1 min-1), doses sufficient to block the vasodilator response of the hepatic artery to exogenously applied adenosine, reduced the magnitude of the 'buffer response' by 50% and 75%, respectively. 5. Intravenous infusion of dipyridamole (100 micrograms kg-1 min-1), a dose sufficient to potentiate the vasodilator response of the hepatic artery to exogenously applied adenosine, had little effect on the 'buffer response'. 6. It is concluded that adenosine is an important, but not the sole, agent responsible for the hepatic arterial 'buffer response'.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697200      PMCID: PMC1917785          DOI: 10.1111/j.1476-5381.1990.tb15857.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Hepatic arterial pressure-flow autoregulation is adenosine mediated.

Authors:  W R Ezzat; W W Lautt
Journal:  Am J Physiol       Date:  1987-04

Review 2.  Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response.

Authors:  W W Lautt
Journal:  Am J Physiol       Date:  1985-11

3.  The use of 8-phenyltheophylline as a competitive antagonist of adenosine and an inhibitor of the intrinsic regulatory mechanism of the hepatic artery.

Authors:  W W Lautt; D J Legare
Journal:  Can J Physiol Pharmacol       Date:  1985-06       Impact factor: 2.273

4.  Relationship between hepatic blood flow and overall metabolism: the hepatic arterial buffer response.

Authors:  W W Lautt
Journal:  Fed Proc       Date:  1983-04

5.  Role of adenosine in local control of intestinal circulation in the dog.

Authors:  H J Granger; C P Norris
Journal:  Circ Res       Date:  1980-06       Impact factor: 17.367

6.  Adenosine antagonist aminophylline attenuates pacing-induced coronary functional hyperemia.

Authors:  J R Randall; C E Jones
Journal:  Am J Physiol       Date:  1985-01

7.  Adenosine in the local regulation of blood flow: a brief overview.

Authors:  R M Berne; R M Knabb; S W Ely; R Rubio
Journal:  Fed Proc       Date:  1983-12

8.  The hepatic arterial blood flow response to portal vein occlusion in the dog: the effect of hepatic denervation.

Authors:  R T Mathie; P H Lam; A M Harper; L H Blumgart
Journal:  Pflugers Arch       Date:  1980-07       Impact factor: 3.657

9.  The hepatic haemodynamic response to acute portal venous blood flow reductions in the dog.

Authors:  R T Mathie; L H Blumgart
Journal:  Pflugers Arch       Date:  1983-11       Impact factor: 3.657

10.  Haemodynamic and metabolic consequences of reversed portal venous blood flow after side-to-side portacaval shunt in the dog.

Authors:  R T Mathie; L H Blumgart
Journal:  Acta Chir Scand       Date:  1987 Nov-Dec
View more
  13 in total

Review 1.  [Small-for-size: experimental findings for liver surgery].

Authors:  C Eipel; K Abshagen; B Vollmar
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

Review 2.  Regulation of hepatic blood flow: the hepatic arterial buffer response revisited.

Authors:  Christian Eipel; Kerstin Abshagen; Brigitte Vollmar
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

3.  A distinct nitric oxide and adenosine A1 receptor dependent hepatic artery vasodilatatory response in the CCl-cirrhotic liver.

Authors:  Alexander Zipprich; Wajahat Z Mehal; Cristina Ripoll; Roberto J Groszmann
Journal:  Liver Int       Date:  2010-05-24       Impact factor: 5.828

Review 4.  Liver function impairment in liver transplantation and after extended hepatectomy.

Authors:  Matteo Serenari; Matteo Cescon; Alessandro Cucchetti; Antonio Daniele Pinna
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

5.  Morphological and biomechanical remodelling of the hepatic artery in a swine model of portal hypertension.

Authors:  Xi-Ju He; Ming-Hua Yu; Wen-Chun Li; Han-Qin Wang; Jing Li; Xing-Chun Peng; Jie Tang; Na Feng; Tie-Zhu Huang
Journal:  Hepatol Int       Date:  2011-09-23       Impact factor: 6.047

6.  The transhepatic action of ATP on the hepatic arterial and portal venous vascular beds of the rabbit: the role of nitric oxide.

Authors:  D J Browse; R T Mathie; I S Benjamin; B Alexander
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

7.  Nitric oxide is the mediator of ATP-induced dilatation of the rabbit hepatic arterial vascular bed.

Authors:  R T Mathie; V Ralevic; B Alexander; G Burnstock
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

8.  Diminished hyperaemic response of the hepatic artery to portal venous occlusion (the buffer response) in Asian hybrid minipigs: a comparison of the response to that observed in dogs.

Authors:  B Alexander; R T Mathie
Journal:  J Comp Physiol B       Date:  1993       Impact factor: 2.200

9.  Characterization of P2X- and P2Y-purinoceptors in the rabbit hepatic arterial vasculature.

Authors:  V Ralevic; R T Mathie; B Alexander; G Burnstock
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

10.  Adenosine-induced dilatation of the rabbit hepatic arterial bed is mediated by A2-purinoceptors.

Authors:  R T Mathie; B Alexander; V Ralevic; G Burnstock
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.